| Derivation of multipotent mesenchymal stromal cells from ovine bone marrow D Vivas, M Caminal, I Oliver‐Vila, J Vives Current Protocols in Stem Cell Biology 44 (1), 2B. 9.1-2B. 9.22, 2018 | 26 | 2018 |
| A reproducible method for the isolation and expansion of ovine mesenchymal stromal cells from bone marrow for use in regenerative medicine preclinical studies M Caminal, R Vélez, RM Rabanal, D Vivas, L Batlle‐Morera, M Aguirre, ... Journal of tissue engineering and regenerative medicine 11 (12), 3408-3416, 2017 | 25 | 2017 |
| Levels of IL-17F and IL-33 correlate with HLA-DR activation in clinical-grade human bone marrow–derived multipotent mesenchymal stromal cell expansion cultures M Grau-Vorster, L Rodríguez, S Torrents-Zapata, D Vivas, M Codinach, ... Cytotherapy 21 (1), 32-40, 2019 | 24 | 2019 |
| Effect of allogeneic cell-based tissue-engineered treatments in a sheep osteonecrosis model A López-Fernández, V Barro, M Ortiz-Hernández, MC Manzanares, ... Tissue Engineering Part A 26 (17-18), 993-1004, 2020 | 11 | 2020 |
| Evaluation of a cell-based osteogenic formulation compliant with good manufacturing practice for use in tissue engineering D Vivas, M Grau-Vorster, I Oliver-Vila, J García-López, J Vives Molecular Biology Reports 47 (7), 5145-5154, 2020 | 4 | 2020 |
| A pilot study of circulating levels of TGF-β1 and TGF-β2 as biomarkers of bone healing in patients with non-hypertrophic pseudoarthrosis of long bones D Chaverri, D Vivas, S Gallardo-Villares, F Granell-Escobar, JA Pinto, ... Bone Reports 16, 101157, 2022 | 3 | 2022 |
Joaquim VivesBanc de Sang i TeixitsVerified email at bst.cat
